GlassScriptPhysician profile
See L Chin
NPI 1255646006
$5,687.25
in general payments reported to CMS, 2019-2025
25 companies · $944 in 2025
The $944 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,020 · 2020: $645 · 2021: $355 · 2022: $1,589 · 2023: $460 · 2024: $673 · 2025: $944.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,077.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,076.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $967.30 | 2021-2025 | Intellis Adaptivestim, Accurian, Inceptiv |
| Relievant Medsystems, INC. | $887.14 | 2021-2023 | Intracept |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $687.76 | 2019-2024 | Relistor |
| Saluda Medical Americas, INC. | $610.20 | 2023-2025 | Evoke, Evoke Scs |
| Pfizer INC. | $344.63 | 2019-2023 | |
| Spr Therapeutics, INC | $290.22 | 2022-2025 | Sprint Pns System |
| Mdd US Operations, LLC | $270.41 | 2019-2020 | |
| Medtronic USA, INC. | $257.82 | 2019-2020 | |
| Boston Scientific Corporation | $257.20 | 2022-2024 | |
| Horizon Therapeutics Plc | $208.06 | 2019-2022 | |
| Scilex Pharmaceuticals INC. | $191.80 | 2019-2023 | Ztlido |
| Abbvie INC. | $132.18 | 2024-2025 | |
| Nevro Corp. | $122.70 | 2024 | Senza |
| Vertos Medical, INC. | $101.10 | 2021-2024 | Mild Device Kit |
| Biotronik Nro, INC. | $69.07 | 2025 | Prospera |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $54.22 | 2019-2020 | |
| Pacira Therapeutics, INC. | $42.94 | 2019 | |
| Abbott Laboratories | $41.32 | 2019-2025 | Proclaim |
| Biohaven Pharmaceutical Holding Company LTD. | $31.98 | 2022 | |
| Si-Bone, INC. | $24.90 | 2020 | |
| Elutia, INC. | $23.11 | 2019 | |
| Fisher & Paykel Healthcare INC | $22.75 | 2025 | Fisher & Paykel Healthcare |
| Painteq LLC | $19.93 | 2022 | |
| Bioventus LLC | $15.57 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $12.94 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw See Chin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.